Stocks›Healthcare›ENOV

ENOV

Enovis Corp
NYSEResearch view

Enovis Corp operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

$18.69+5.18%
Oct 5 close · 1D EOD · Databento
HealthcareOrthopedic, Prosthetic & Surgical Appliances & SuppliesSmall-capSEC EDGAR FY 2025-12-31

The numbers · FY2025, filed

SEC EDGAR
Market cap$1.0B
Revenue$2.2B+6.70%
Net income$-1.2B
EPS, diluted$-20.75−39.00%
Gross margin59.8%
Operating margin-50.0%
All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$1.0B
Enterprise Value$2.3B
Income$-1.2B
Sales$2.2B
Book/sh$25.87
Cash/sh$0.63
Dividend TTM—
Payout0%
Employees—
IPO—
Quick Ratio1.04
Current Ratio2.02
Debt/Eq0.89
EPS (ttm)$-20.75
EPS this Y-39.0%
EPS past 3/5Y—
Sales past 3/5Y12.9%
EPS Y/Y TTM-39.0%
Sales Y/Y TTM6.7%
Shs Outstand57.67M
ROA-30.9%
ROE-79.4%
ROIC-41.1%
Gross Margin59.8%
Oper. Margin-50.0%
Profit Margin-52.7%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$1.4B
FY21
$1.6B
FY22
$1.7B
FY23
$2.1B
FY24
$2.2B
FY25

Operating leverage — margins

GrossOperatingNet
0%40%80%60%-50%-53%FY21FY22FY23FY24FY25
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.